December 7, 2016
Last week I had the honor of chairing Day One afternoon sessions for a new conference called ManuPharma held in Frankfurt, Germany. This elite gathering of technology practitioners ranging from the Heads of Tech Ops to Site Leads at the top Pharma companies came together to explore and learn about a range of disruptive technologies – Internet of Things, Additive Manufacturing (3D Printing), Industry 4.0, Advanced Manufacturing Technology, Continuous Manufacturing, QbD & Process Control, MES, Data Integrity among others.
From the case study presentations to the informal networking opportunities, it was a very enriching and worthwhile event. Digitalization was a key theme and it was acknowledged that Pharma has traditionally been a late adopter due to the highly regulated nature, consumer privacy considerations and the basic complexity of operating a global company. With greater acceptance of cloud and Big Data, Pharma companies are now aggressively looking at the best ways to digitalize their end-to-end supply chain to gain a competitive advatage. I was very impressed by the keynote presentation by Thierry Hulot, EVP, Head of Global Manufacturing and Supply, at Merck KGaA.
This conference definitely serves as an enabler for the future of Pharma manufacturing advancements. From the conversations I had, attendees felt this event was a great break from the regular routine to put time into learning best practices and new implementation strategies from peers and consider the value new technologies can offer for supply chain excellence. For my part, it was a chance to also gain the validation about just how urgent the need for unified supply chain intelligence in order to help Pharma companies reduce complexity, adhere to regulations, deliver better customer experience and innovate to stay ahead of the competition.
Thanks to the organizers of ManuPharma, I am certainly looking forward to seeing what amazing progress is made by attending next year’s conference.